title: Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study.
abstract: BACKGROUND
  Limited information exists on the frequency, trends in occurrence, risk factors, mechanisms, and outcome of ischemic stroke associated with illicit drug use among young adults in a geographically defined population.
  
  
  METHODS
  We reviewed ischemic stroke in young adults (aged 15 to 44 years) in 46 regional hospitals for 1988 and 1991. We examined stroke mechanisms and outcome in patients with recent drug use.
  
  
  RESULTS
  Recent illicit drug use was noted in 51/422 (12.1%) stroke patients. Patients with drug use were more likely than other stroke patients to be black (p=0.01), aged 25 to 39 years (p=0.004), and smokers (p=0.006), and were less likely to have hypertension (p=0.004) or diabetes mellitus (p=0.004). Drug use was the probable cause of stroke in 20 (4.7%) patients. Among 31 (7.3%) patients with drug use as a possible stroke mechanism, more likely diagnoses included cardioembolic stroke in 18, hematologic/collagen vascular in 6, nonatherosclerotic vasculopathy in 5, and atherosclerosis in 3. There was no difference in outcome between drug-associated and non-drug associated stroke.
  
  
  CONCLUSIONS
  Recent illicit drug use occurs in 12.1% of young adult stroke patients. Drug-associated young adult stroke seems to relate to vascular mechanisms other than those related to hypertension or diabetes. Case-control studies are needed.
authors.affiliation: Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Sloan
authors.forename: S J
authors.initials: SJ
authors.lastname: Kittner
authors.forename: B R
authors.initials: BR
authors.lastname: Feeser
authors.forename: J
authors.initials: J
authors.lastname: Gardner
authors.forename: A
authors.initials: A
authors.lastname: Epstein
authors.forename: M A
authors.initials: MA
authors.lastname: Wozniak
authors.forename: R J
authors.initials: RJ
authors.lastname: Wityk
authors.forename: B J
authors.initials: BJ
authors.lastname: Stern
authors.forename: T R
authors.initials: TR
authors.lastname: Price
authors.forename: R F
authors.initials: RF
authors.lastname: Macko
authors.forename: C J
authors.initials: CJ
authors.lastname: Johnson
authors.forename: C J
authors.initials: CJ
authors.lastname: Earley
authors.forename: D
authors.initials: D
authors.lastname: Buchholz
mesh_terms: D000293:Adolescent; D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data; D002545:Brain Ischemia / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D015994:Incidence; D008297:Male; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000208:ethnology; D014505:Urban Population; D044465:White People / Q000706:statistics & numerical data
chemical_list: D013287:Illicit Drugs